ABT Stock Recent News

Abbott Laboratories' top line was somewhat inconsistent in recent years due to swings in its COVID-related revenues. Johnson & Johnson has been restructuring, spinning off its consumer health segment and bolstering its medical device segment by acquiring Abiomed.

The ProShares S&P 500 Dividend Aristocrats ETF extends it's good form in the second half of 2024, adding a gain of 3.69% in August. I present 3 strategies that can theoretically beat the dividend aristocrat index in the long term. After 38 months of tracking these strategies, all 3 strategies are generating a CAGR superior to NOBL while also offering a higher starting dividend yield.

Abbott (ABT) closed the most recent trading day at $112.73, moving +0.11% from the previous trading session.

To help address the greatest need for blood in a generation, Abbott, a global leader in blood testing, and the Big Ten Conference are teaming up to host the first college conference-wide blood donation competition The school that drives the most blood donations during the 2024 football season will be honored by Abbott at the Discover Big Ten Football Championship Game with a $1 million donation to the school to advance student or community health Students, alumni and fans can donate blood on behalf of any of the 18 member schools at blood centers across the country; donation totals will be tracked live at BigTen.Org/Abbott throughout the campaign Participants receive a free one-month subscription to B1G+ streaming service and are entered to win two tickets and a trip to the Big Ten Football Championship Game ABBOTT PARK, Ill. and ROSEMONT, Ill.

ABBOTT PARK, Ill., Sept. 19, 2024 /PRNewswire/ -- The board of directors of Abbott (NYSE: ABT) today declared a quarterly common dividend of 55 cents per share.

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Investors interested in stocks from the Medical - Products sector have probably already heard of Phibro Animal Health (PAHC) and Abbott (ABT). But which of these two stocks offers value investors a better bang for their buck right now?

Abbott (ABT) reachead $117.63 at the closing of the latest trading day, reflecting a +1.06% change compared to its last close.

Abbott's diversified growth, driven by innovative medical devices and established pharmaceuticals, positions it well for long-term success and market outperformance. Despite legal challenges and post-pandemic headwinds, Abbott's robust earnings growth and solid dividend profile make it an attractive investment. Abbott's strong innovation pipeline, including advancements in CGM systems, supports its market share gains and growth outlook.

These two companies have been leaders in the healthcare industry for a long time. Both have solid underlying businesses and belong in the group of Dividend Kings.